Start-ups and tech giants are the future of pharma marketingWe are living in a revolutionary time of scientific change and innovation in pharma marketing – and the Share XStart-ups and tech giants are the future of pharma marketinghttps://pharmaphorum.com/sales-marketing/start-ups-and-tech-giants-are-the-future-of-pharma-marketing/
Marketing science – brand innovation for pharmaCombining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as Share XMarketing science – brand innovation for pharmahttps://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/
Remote HCP engagement – still a struggle for life science companiesLife science companies are failing to achieve their full digital potential, particularly when it comes to the use Share XRemote HCP engagement – still a struggle for life science companieshttps://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/
Thinking niche: the challenge of pharma’s focus on small patient populationsWith the pharma industry putting the ‘blockbuster’ age behind it and moving into meeting needs across myriad niche Share XThinking niche: the challenge of pharma’s focus on small patient populationshttps://pharmaphorum.com/white-papers/thinking-niche-the-challenge-of-pharmas-focus-on-small-patient-populations/
Pharma brand strategy: Transforming lives with rich insightThe mighty power of true insight lays in its ability to turn data into a brand strategy that Share XPharma brand strategy: Transforming lives with rich insighthttps://pharmaphorum.com/whitepapers/pharma-brand-strategy-transforming-lives-with-rich-insight/
Standing on the cusp of something great: How real-world data is poised to transform cancer careREAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care How can real world evidence (RWE) improve the Share XStanding on the cusp of something great: How real-world data is poised to transform cancer carehttps://pharmaphorum.com/whitepapers/standing-cusp-something-great-real-world-data-poised-transform-cancer-care/
Pricing and Market Access Outlook 2018This year’s edition of Pricing and Market Access Outlook, our first as IQVIA, identifies a trend towards models Share XPricing and Market Access Outlook 2018https://pharmaphorum.com/whitepapers/pricing-market-access-outlook-2018/
Definitive Guide to Global Transparency Regulations for the Life Sciences In 2015, Zephyr Health released its first ‘Definitive Guide to Global Life Sciences Transparency Regulations’, outlining the Share XDefinitive Guide to Global Transparency Regulations for the Life Scienceshttps://pharmaphorum.com/whitepapers/transparency-regulations-life-sciences/
Touchpoint optimisation: time for multichannel marketing to reconnect the brand story and the customer As the digital era of communication continues to expand and flourish, the way life sciences companies interact Share XTouchpoint optimisation: time for multichannel marketing to reconnect the brand story and the customerhttps://pharmaphorum.com/debates-insight-sales-marketing/touchpoint-optimisation-time-multichannel-marketing-reconnect-brand-story-customer/
